Author Topic: Lancet Commission on the Value of Death  (Read 306 times)

John Short

  • Global Moderator
  • PFM Member
  • *****
  • Posts: 558
Lancet Commission on the Value of Death
« on: October 17, 2018, 08:58:28 GMT »
Interesting issues raised relating to health expenditures

John Short

  • Global Moderator
  • PFM Member
  • *****
  • Posts: 558
Re: Lancet Commission on the Value of Death
« Reply #1 on: October 19, 2018, 18:46:49 GMT »
related article also in The Lancet

John Short

  • Global Moderator
  • PFM Member
  • *****
  • Posts: 558
Re: Lancet Commission on the Value of Death
« Reply #2 on: October 26, 2018, 11:23:07 GMT »

Changes in health in the countries of the UK and 150 English Local Authority areas 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
The Lancet Vol.392
Number 10157 | Oct 27, 2018
| p 1487​-​1598

Methodological approach for resource allocation in health

Interpretation
These estimates at local, regional, and national level will allow policy makers to match resources and priorities to levels of burden and risk factors. Improvement in YLLs and life expectancy slowed notably after 2010, particularly in cardiovascular disease and cancer, and targeted actions are needed if the rate of improvement is to recover. A targeted policy response is also required to address the increasing proportion of burden due to morbidity, such as musculoskeletal problems and depression. Improving the quality and completeness of available data on these causes is an essential component of this response.

 

RSS | Mobile

© 2002-2024 Taperssection.com
Powered by SMF